Nordic and BeeKeeperAI Partner | To Accelerate AI-driven Clinical Decision Support at the Point of Care

Nordic, a global health and technology consulting company, and BeeKeeperAI®, Inc. a pioneer in privacy-enhancing, multi-party collaboration software for real-world AI development and deployment, announced today a strategic partnership to bring to market a new real-world, end-to-end RightAI™ solution that is aimed at connecting biopharmaceutical and medical technology companies, healthcare delivery organizations, and physicians in the development, validation, and deployment of AI and machine learning-based CDSS tools that support clinical workflows within electronic health record (EHR) systems.

The partnership intends for RightAI to assist physicians with optimizing patient outcomes through the use of native CDSS tools within the EHR and support efforts to identify patients who are optimal candidates for clinical trials.

Precise decision-making at the point of care can be difficult given a variety of factors, such as a patient’s unique clinical characteristics, chronic conditions, and the complexities of biological and disease factors. The development of a new standard of care resulting from the collaboration between biopharmaceutical and medical technology companies and healthcare systems can enable new personalized care programs, provide novel therapies, and meet patients’ goals for better health. RightAI seeks to offer solutions that enable clinicians to identify these optimal treatment plans for the right patient at the right time. Leveraging the power of data at the point of care from this collaboration can transform care delivery.

“By embracing AI in healthcare, we are transforming how care is delivered and setting a new standard for patient-centered, personalized, and efficient care,” said Nordic Chief Medical Officer Craig Joseph, MD. “Our partnership with BeeKeeperAI and the integration of RightAI into the EHR allows us to introduce AI models that create real-world impact and drive better patient outcomes.”

Along with the potential both to unlock data insights and enable more precise therapeutic decisions by clinicians, RightAI also intends to accelerate time-to-market for AI developers building CDSSs and other machine learning solutions for healthcare. Biopharmaceutical and medical technology companies offering therapies for complex diseases can leverage RightAI to assist with the development of CDSSs based on real-world data and quickly achieve real-world impacts.

“Together with Nordic, BeeKeeperAI’s privacy enhancing platform can address the last mile of AI/machine learning-based CDSS: real-world deployment and ongoing monitoring for performance drift. The ability to develop and deploy solutions in real-world settings enhances and accelerates the impact of CDSS,” said Michael Blum, MD, co-founder and chief executive officer at BeeKeeperAI. “Instead of taking years to achieve impact, RightAI will enable CDSS to impact patient outcomes in a matter of months from the start of development to impact. This acceleration will enable life-changing therapies to reach patients more quickly, fulfilling the promise of healthcare AI.”

Dr. Joseph added, “Following the guiding principles of clinical decision support, RightAI brings the right information to the right provider in the right format through the right channels at the right time to help clinicians improve the precision of their treatment decisions for their patients.”

The partnership continues Nordic and BeeKeeperAI’s leadership in the healthcare AI space. Nordic is a comprehensive delivery partner of BeeKeeperAI’s EscrowAI™, a privacy-enhancing collaboration platform for trustworthy and responsible AI that enables data controllers to maintain control and protect the privacy of their real-world patient data and developers to responsibly develop and deploy AI into the EHR and clinical workflows.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.